Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Diseases (9)
- Eye Diseases (8)
- Medical Sciences (8)
- Life Sciences (7)
- Bioinformatics (6)
-
- Biomedical Informatics (6)
- Oncology (6)
- Medical Genetics (4)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (3)
- Genetic Phenomena (3)
- Neoplasms (2)
- Optometry (2)
- Surgery (2)
- Biological Phenomena, Cell Phenomena, and Immunity (1)
- Chemicals and Drugs (1)
- Diagnosis (1)
- Endocrinology, Diabetes, and Metabolism (1)
- Genetics and Genomics (1)
- Investigative Techniques (1)
- Medical Cell Biology (1)
- Neurology (1)
- Therapeutics (1)
- Publication Year
Articles 31 - 32 of 32
Full-Text Articles in Ophthalmology
Giant Fornix Syndrome: A Case Series., Kiran Turaka, Robert B Penne, Christopher J. Rapuano, Azin Abazari, Ralph C Eagle, Kristin M. Hammersmith, Brandon Ayres
Giant Fornix Syndrome: A Case Series., Kiran Turaka, Robert B Penne, Christopher J. Rapuano, Azin Abazari, Ralph C Eagle, Kristin M. Hammersmith, Brandon Ayres
Wills Eye Hospital Papers
PURPOSE: To describe the demographics, characteristics, and treatment of giant fornix syndrome, a rare cause of chronic purulent conjunctivitis in the elderly.
METHODS: Retrospective chart review of five patients with giant fornix syndrome evaluated by the Cornea Service, Oculoplastics and Orbital Surgery Service and the Department of Pathology at the Wills Eye Institute.
RESULTS: The median age of the 5 female patients was 75 years (mean 80, range 70-95). The median duration of eye symptoms before presentation was 2 years (mean 2.4, range 1-4). Before referral, the chronic conjunctivitis was treated with topical antibiotics in all 5 cases and with …
Postenucleation Adjuvant Chemotherapy With Vincristine, Etoposide, And Carboplatin For The Treatment Of High-Risk Retinoblastoma., Swathi Kaliki, Carol L Shields, Sanket U Shah, Ralph C Eagle, Jerry A Shields, Ann Leahey
Postenucleation Adjuvant Chemotherapy With Vincristine, Etoposide, And Carboplatin For The Treatment Of High-Risk Retinoblastoma., Swathi Kaliki, Carol L Shields, Sanket U Shah, Ralph C Eagle, Jerry A Shields, Ann Leahey
Wills Eye Hospital Papers
BACKGROUND: Analysis of 52 eyes with high-risk retinoblastoma managed with postenucleation adjuvant chemotherapy using vincristine sulfate, etoposide phosphate, and carboplatin showed no evidence of systemic metastasis in any case during a mean (range) follow-up of 66 (12-202) months.
PURPOSE: To determine the efficacy of postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin in the prevention of metastasis for patients with high-risk retinoblastoma.
METHODS: Retrospective, nonrandomized, interventional case series of 52 eyes in 51 patients with high-risk retinoblastoma consisting of tumor invasion into the anterior segment, posterior uvea 3 mm or greater, postlaminar optic nerve, or any combination of posterior uvea …